Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (14)

2019

  1. How computational chemistry develops: a tribute to Peter Goodford

    Journal of Computer-Aided Molecular Design

2016

  1. Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 79-87

  2. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: A cross-national descriptive study from the PROTECT-EU Project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 56-65

  3. Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): A methodological approach to assess consistencies across databases from the PROTECT-EU project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 66-78

  4. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 156-165

  5. Prevalence of antibiotic use: A comparison across various European health care data sources

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 11-20

  6. Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 29-38

  7. The IMI PROTECT project: Purpose, organizational structure, and procedures

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 5-10

  8. Understanding inconsistency in the results from observational pharmacoepidemiological studies: The case of antidepressant use and risk of hip/femur fractures

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 88-102

2015

  1. Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs

    Respiratory Medicine, Vol. 109, Núm. 7, pp. 828-837

2014

  1. Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications

    European Journal of Clinical Pharmacology, Vol. 70, Núm. 7, pp. 849-857

  2. Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison

    Epilepsia, Vol. 55, Núm. 5, pp. 666-673

  3. Ascertainment of acute liver injury in two European primary care databases

    European Journal of Clinical Pharmacology, Vol. 70, Núm. 10, pp. 1227-1235

  4. Incidence rates and trends of hip/femur fractures in five European countries: Comparison using e-healthcare records databases

    Calcified Tissue International, Vol. 94, Núm. 6, pp. 580-589